Targeted therapy has been proven to be one of the most effective cancer treatments. However, some endocrine disorders can occur during treatment with targeted agents. We report the case of a patient who exhibited a wax and wane pattern of hypoglycemia that was attributed to sorafenib therapy. A 32-year-old woman with metastatic hemangiopericytoma visited the emergency department in a stuporous state. Nonhyperinsulinemic hypoglycemia was diagnosed, was exacerbated shortly after sorafenib therapy, and was improved by the cessation of sorafenib with additional glucocorticoid therapy. Patients with metastatic hemangiopericytoma should be carefully monitored with particular attention to hypoglycemia when sorafenib therapy is initiated.

Citations

Citations to this article as recorded by  

• Refractory hypoglycemia is sensitive to octreotide therapy: is it triggered by sorafenib or hepatocellular carcinoma?
  Mehmet Çakmak, Öznur Bal, Murat Kiraci, Oya Topaloğlu, Fahriye Tuğba Köş, Efnan Algin
  Anti-Cancer Drugs.2025; 36(2): 140.     CrossRef
• Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor
  Muhammed Muhiddin Er, Murat Araz, Meryem Karabacak, Muzaffer Uğraklı, Melek Karakurt Eryılmaz, Mustafa Karaağaç, Mehmet Artaç
  Journal of Oncology Pharmacy Practice.2021; 27(8): 2049.     CrossRef
• Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis
  Minglin Lin, Junfei Jin
  Nature Reviews Clinical Oncology.2017; 14(5): 268.     CrossRef
• Multidisciplinary Approach to Hepatic Metastases of Intracranial Hemangiopericytoma: A Case Report and Review of the Literature
  Dimitrios K. Manatakis, Spiridon G. Delis, Nikolaos Ptohis, Penelope Korkolopoulou, Christos Dervenis
  Case Reports in Oncological Medicine.2015; 2015: 1.     CrossRef
• Articles in 'Endocrinology and Metabolism' in 2014
  Won-Young Lee
  Endocrinology and Metabolism.2015; 30(1): 47.     CrossRef
• Case report of severe Cushing’s syndrome in medullary thyroid cancer complicated by functional diabetes insipidus, aortic dissection, jejunal intussusception, and paraneoplastic dysautonomia: remission with sorafenib without reduction in cortisol concentr
  Muhammad M. Hammami, Najla Duaiji, Ghazi Mutairi, Sabah Aklabi, Nasser Qattan, Mohei El-Din M. Abouzied, Mohamed W. Sous
  BMC Cancer.2015;[Epub]     CrossRef